DOJ says it will seek U.S. Supreme Court review of abortion pill ruling

The U.S. Department of Justice "strongly disagrees" with an appeals court decision banning telemedicine prescriptions and mail-order shipments of the abortion pill mifepristone and will seek a review by the U.S. Supreme Court, a DOJ spokesperson said.

The New Orleans-based 5th U.S. Circuit Court of Appeals stopped short of ruling that the drug must be pulled off the market altogether, as a lower court had done. The latest decision will not take effect until the Supreme Court reviews it.